J Breast Cancer.
2018 Jun;21(2):232-232. 10.4048/jbc.2018.21.2.232.
Erratum: Development of a Nomogram to Predict N2 or N3 Stage in T1-2 Invasive Breast Cancer Patients with No Palpable Lymphadenopathy
- Affiliations
-
- 1Division of Breast and Endocrine Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. seokwon1.kim@samsung.com
- KMID: 2413945
- DOI: http://doi.org/10.4048/jbc.2018.21.2.232
Abstract
- This article was initially published on the Journal of Breast Cancer with a misspelled the name of third author.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Development of a Nomogram to Predict N2 or N3 Stage in T1–2 Invasive Breast Cancer Patients with No Palpable Lymphadenopathy
- Preoperative Staging in Non-Small Cell Lung Cancer without Lymphadenopathy on Computed Tomogram
- A Novel Prognostic Nomogram for Predicting Risks of Distant Failure in Patients with Invasive Breast Cancer Following Postoperative Adjuvant Radiotherapy
- Development and Validation of Web-Based Nomograms to Predict Postoperative Invasive Component in Ductal Carcinoma in Situ at Needle Breast Biopsy
- A Clinical Analysis of the Characteristics of the Lymph Node Metastasis in Patients with Gastrics Cancer
